Humana Balance Sheet Health

Financial Health criteria checks 4/6

Humana has a total shareholder equity of $16.2B and total debt of $13.5B, which brings its debt-to-equity ratio to 83.7%. Its total assets and total liabilities are $50.1B and $33.9B respectively. Humana's EBIT is $4.1B making its interest coverage ratio 7.6. It has cash and short-term investments of $22.6B.

Key information

83.7%

Debt to equity ratio

US$13.55b

Debt

Interest coverage ratio7.6x
CashUS$22.61b
EquityUS$16.19b
Total liabilitiesUS$33.91b
Total assetsUS$50.09b

Recent financial health updates

Recent updates

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Apr 22
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Apr 20
Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana: Where To Buy This

Apr 02

Humana: This Year's Drop Might Have Created A Buying Opportunity

Mar 19

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Feb 03

Humana: The $300 Level Could Get Taken Out In The Near Future

Jan 25

Humana: My Oh My, Another Strong Buy

Jan 14

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Jan 02

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Dec 14
Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Dec 11

Humana: Upgrade To Buy

Oct 06

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Sep 27

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Aug 25
We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana: Mr. Market Got This One Right

Aug 03

Humana: Recent Selloff Might Present A Buying Opportunity

Jul 13

Humana: Rising Medical Costs Should Be Temporary

Jun 28

Humana: Margin Expansion Supported By Growing Memberships

Jun 12

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

May 26
Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 13
Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Humana Q4 2022 Earnings Preview

Jan 31

Humana: Destined For A Long-Term Success

Jan 23

Humana (NYSE:HUM) Could Easily Take On More Debt

Jan 13
Humana (NYSE:HUM) Could Easily Take On More Debt

Humana receives $70.85B contract from Defense Health Agency

Dec 22

Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Dec 20
Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Humana: Top-Rated Medicare Advantage Insurer With Room To Grow

Nov 14

Humana prices $1.23B debt offering

Nov 08

Humana Q3 2022 Earnings Preview

Nov 01

Humana expands partnership with Cohere Health on prior authorization services

Oct 24

Humana announces major expansion of Florida Dental Network, benefits

Oct 17

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Oct 10
We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana Inc.'s (NYSE:HUM) Intrinsic Value Is Potentially 92% Above Its Share Price

Sep 21
Humana Inc.'s (NYSE:HUM) Intrinsic Value Is Potentially 92% Above Its Share Price

Humana adds 9%, highest in over two years, after lifting guidance

Sep 15

Humana: Time To Adopt A More Defensive Portfolio Strategy

Sep 04

Humana declares $0.7875 dividend

Aug 18

Humana to acquire Wisconsin managed care organization Inclusa

Aug 12

Financial Position Analysis

Short Term Liabilities: HUM's short term assets ($32.8B) exceed its short term liabilities ($19.7B).

Long Term Liabilities: HUM's short term assets ($32.8B) exceed its long term liabilities ($14.2B).


Debt to Equity History and Analysis

Debt Level: HUM has more cash than its total debt.

Reducing Debt: HUM's debt to equity ratio has increased from 57.6% to 83.7% over the past 5 years.

Debt Coverage: HUM's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: HUM's interest payments on its debt are well covered by EBIT (7.6x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.